GNS and breast carcinoma: In summary, our in vivo work has provided proof-of-principle data demonstrating the antitumor efficacy of AS1411-GNS in a mouse model of breast cancer, while our cell-based studies have added to the expansive data supporting the ability of AS1411 to deliver cargoes efficiently and selectively to the inside of cancer cells.